Dendrimer mediated clustering of bacteria: improved aggregation and evaluation of bacterial response and viability by Leire, Emma et al.
Leire, Emma and Amaral, Sandra P. and Louzao, Iria 
and Winzer, Klaus and Alexander, Cameron and 
Fernandez-Megia, Eduardo and Fernandez-Trillo, 
Francisco (2016) Dendrimer mediated clustering of 
bacteria: improved aggregation and evaluation of 
bacterial response and viability. Biomaterials Science, 4 
(6). pp. 998-1006. ISSN 2047-4830 
Access from the University of Nottingham repository: 
http://eprints.nottingham.ac.uk/39101/1/Leire%20et%20al%20Biomater%20Sci
%202016%20AAM.pdf
Copyright and reuse: 
The Nottingham ePrints service makes this work by researchers of the University of 
Nottingham available open access under the following conditions.
This article is made available under the University of Nottingham End User licence and may 
be reused according to the conditions of the licence.  For more details see: 
http://eprints.nottingham.ac.uk/end_user_agreement.pdf
A note on versions: 
The version presented here may differ from the published version or from the version of 
record. If you wish to cite this item you are advised to consult the publisher’s version. Please 
see the repository url above for details on accessing the published version and note that 
access may require a subscription.
For more information, please contact eprints@nottingham.ac.uk
Please do not adjust margins 
This journal is © The Royal Society of Chemistry   20xx J. Name., 2013, 00, 1-3 |   1 
 
 
 
 
 
 
Journal Name 
 
 
 
 
 
 
 
Received 00th January 20xx, 
Accepted 00th January 20xx 
 
DOI: 10.1039/x0xx00000x 
 
www.rsc.org/ 
Dendrimer mediated clustering of bacteria: Improved aggregation 
and  evaluation  of bacterial response  and viability. 
Emma Leire,
a,b 
Sandra P. Amaral,
a 
Iria Louzao,
b,c 
Klaus Winzer,
d 
Cameron Alexander,
b,
* Eduardo 
Fernandez-Megia
a,
* and Francisco Fernandez-Trillo
e,
* 
Here, we evaluate how cationic gallic acid-triethylene glycol (GATG) dendrimers interact with bacteria and their potential 
to develop new antimicrobials. We demonstrate that GATG dendrimers functionalised with primary amines in their 
periphery can induce the formation of clusters in Vibrio harveyi, an opportunistic marine pathogen, in a generation 
dependent manner. Moreover, these cationic GATG dendrimers demonstrate an improved ability to induce cluster 
formation when compared to poly(N-[3-(dimethylamino)propyl]methacrylamide) [p(DMAPMAm)], a cationic linear 
polymer previously shown to cluster bacteria. Viability of the bacteria within the formed clusters and evaluation of  
quorum sense controlled phenotypes (i.e. light production in Vibrio harveyi) suggests that GATG dendrimers may be 
activating microbial responses by maintaining a high concentration of quorum sensing signals inside the clusters while 
increasing permeability of the microbial outer membranes. Thus, the reported GATG dendrimers constitute a valuable 
platform for the development of novel antimicrobial materials that can target microbial viability and/or virulence. 
 
 
Introduction 
terials to target these aspects of infections, reporting the bac- 
terial clustering  effect of  cationic  polymers with Gram-positive 
12 
In recent years there has been an increase in the prevalence   of and  Gram-negative bacteria. Polymers  are  inherently multi- 
microbial strains that can resist the action of current antibiot- 
ics.
1, 2  
To overcome this resistance a significant effort has   been 
valent  and  thus  can  be  designed  to  outcompete  the  ligand- 
binding  interactions  observed  during  the  adhesion  of  patho- 
13 
placed both  in  the  development of  new  classes  of antibiotics, gens  and  toxins  to hosts. Since  this  adhesion  is  heavily af- 
but also in exploring novel antimicrobial strategies
3, 4 
which 
minimise  the  impact  of  infection  without  targeting microbial 
fected by  the  spatial arrangement of the  ligands, it is  not   sur- 
prising that a major effort has been placed in using   dendrimers 
14, 15 
viability.
5  
Anti-virulence methods target key stages in   infection for  preventing  microbial attachment. Indeed,  the mono- 
such as the adhesion of the pathogen to the host
6, 7 
or the sig- dispersity of dendrimers is a key advantage when    interpreting 16 
nalling  networks  that  coordinate  the  expression  of virulence affinity  data  in  term  of  size  and multivalency. However, ad- 
factors.
8, 9 
Because these strategies do not compromise micro- 
bial  viability  and  survival,  the  evolutionary  pressure imposed 
hesion  of  polymers to  bacteria surfaces can  result in  the clus- 
tering  of  these  bacteria and  the  activation of  signalling within 
17, 18 
on microbes is much smaller than with conventional  antibiotics those clusters. Polymeric materials are  now  starting  to be 
and hence, resistance is less likely to develop.
10 
Moreover, an- ti-
virulence strategies can  be  combined with  other  antimicro- 
reported as relevant alternatives to modulate microbial   signal- 
ling  where they  can  passively and  actively  target these signal- 
19-25 
bial treatments to obtain synergistic  benefits.
11
 
We, and others, have been exploring the use of polymeric   ma- 
ling networks. 
Alternatively, polymeric materials have been investigated as 
readily accessible mimics of antimicrobial peptides.
26-28 
These 
antimicrobial polymers exert a bactericidal effect by targeting 
bacterial membranes. The combination of cationic charge and 
hydrophobic character in antimicrobial polymers gives them 
interesting membrane properties, including increasing cell 
membrane permeability, that can result in bactericidal activity 
through lysis. 
Here, we investigate the use of gallic acid-triethylene glycol 
(GATG) dendrimers
29 
as a platform for the development of  
novel antimicrobial agents. We have focussed our attention in  
3 areas – adhesion/clustering, signalling and membrane dis- 
ruption – because of the relevance of polymeric materials. The 
presence  of  terminal azides  in  GATG  and  their  derivatives in- 
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troduces great flexibility in their peripheral decoration. These 
azides can be easily functionalized using highly efficient click- 
chemistries, and not surprisingly, the resulting materials have 
found application in the study of receptor-ligand  interactions
30,
 
31 
and cell internalization,
32 
to interfere with protein-protein 
interactions
33 
and amyloid formation,
34 
or as imaging agents.
35 
Moreover, these azides can be easily reduced to give primary 
amines and afford cationic dendrimers that have been applied  
in gene delivery.
36, 37 
Bacteria are negatively charged, so cati- 
onic materials are also an obvious starting point in the devel- 
opment of antimicrobial agents that cluster bacteria,
12, 17, 18 
potentially inhibiting their adhesion to the host. In addition, 
adhesion of cationic materials to bacterial membranes can re- 
sult in membrane damage and bactericidal activity.
26-28
 
Using Vibrio harveyi as a model organism, here we demon- 
strate that three generations of  GATG  dendrimers carrying 9, 
27 and 81 primary amines in their periphery (Scheme 1) induce 
clustering of bacteria in a generation dependent fashion and 
that their ability to cluster bacteria is higher than  
p(DMAPMAm), a cationic linear polymer previously used in our 
laboratories. Also, we demonstrate that quorum sense con- 
trolled expression of luminescence by V. harveyi is activated in  
a generation dependent fashion, in agreement with the clus- 
tering observed. Finally, we evaluate if these GATG can induce 
membrane damage and elicit a potential bactericidal  effect. 
 
Experimental 
Materials 
Triphenyl phosphine was purchased from Sigma-Aldrich® and 
recrystallized from ethanol. Phosphate Buffer Saline (PBS, Dul- 
becco A) was purchased from Oxoid. 4,5-Dihydroxy-2,3- 
pentandione (DPD) was purchased from Ommcientific®. 
p(DMAPMAm), degree of polymerisation 46 and 99, was syn- 
thesised according to protocols  described  in  the  literature
18
. All   
other  chemicals  were  purchased  from   Sigma-Aldrich   or 
Acros and were used without further purification. All solvents 
were of HPLC grade and purchased from Sigma-Aldrich  or 
Fisher Scientific and used without further purification. Bac- 
light  Bacterial  Viability  kit  (L32856)  was  purchased  from 
Life technologies  and  used  for  fluorescent  live/dead staining 
for flow cytometry and Confocal Laser Scanning Microscopy 
(CLSM). When possible, experiments have been done in tripli- 
cate. Mean values and standard deviations are reported unless 
otherwise stated. 
Instrumentation 
Nuclear Magnetic Resonance (NMR) spectra were recorded on  
a Varian NMR Inova 500MHz spectrometer. Chemical shifts are 
reported in ppm ( units) downfield from solvent peak (CD3OD 
or CDCl3). FT-IR spectra were recorded on a Bruker IFS-66v us- 
ing  KBr pellets  or  neat samples (CsI window). MALDI-TOF MS  
of the dendrimers at the azide stage were performed  on  a  
4800 MALDI-TOF/TOF analyser (Applied Biosystems) with 
samples dissolved in MeOH supplemented with NaCl as cation- 
izing agent, and 2-(4-hydroxyphenylazo)benzoic acid (HABA) or 
2,5-dihydroxybenzoic acid (DHB) as matrixes. Dendrimer hy- 
drodynamic diameters and ζ-potentials were measured by dy- 
namic light scattering (DLS) and laser Doppler micro- 
electrophoresis on a Nano-S Zetasizer  (Malvern  Instrument  
Ltd) at 25 C.  Molecular  weight  distributions  were  measured 
by size exclusion chromatography (SEC) on an Agilent 1100 se- 
ries separation module using a PSS SDV pre-column (5 m, 8 x 
50 mm), a PSS SDV Linear S column (5 m, 8 x 300 mm) and a 
PSS SDV Lux Linear M column (5 m, 8 x 300 mm) with an Ag- 
ilent 1100 series refractive index (RI) detector with THF as the 
eluent at 1mL/min flow rate and filtered through 0.45 m be- 
fore injection. Size of bacterial clusters was measured on a 
Coulter LS230 particle size analyser (Beckman Coulter, High 
Wycombe, USA) using laser diffraction. ζ-potential for bacteria 
clusters was measured on a NanoZS ZEN3600 Malvern Zetasiz- 
er. An L3001 Epifluorescent Microscope was used for optical 
imaging. A  Zeiss  LSM  880  confocal laser  microscope was used 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1: A) Chemical structure of cationic GATG dendrimer (G1-NH2 is depicted) and B) interaction of GATG dendrimers with bacteria. Increasing generation (and multiva- 
lency) increases the ability of Gn-NH2 dendrimers to cluster bacteria. Similarly, increasing generation increases membrane permeability and enhances quorum sense con- 
trolled production of light in V. harveyi. Dendrimers and bacteria are not to scale. 
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for fluorescent microscopy imaging. Labelling of the dendrimer 
was confirmed by a Cary Eclipse fluorimeter. Flow cytometry 
was performed on a BD LSRII Flow Cytometer. Luminescence  
and OD600  were measured in a Tecan Infinite Pro 200  Reader. 
Dendrimer synthesis 
Three generations of cationic GATG dendrimers  (3[Gn]-  
NH2·HCl (n = 1,2,3), abbreviated as Gn-NH2) incorporating an 
aromatic trivalent core were synthesized through modification 
of a previously published route.
38-40 
In brief, terminal azides in 
GATG dendrimers were reduced through a Staudinger reaction 
with PPh3 in a MeOH – CHCl3 – H2O mixture and then proto- 
nated with HCl to obtain Gn-NH2·HCl dendrimers. Reactions 
were monitored by 
1
H-NMR (disappearance of the CH2N3 sig-  
nal at 3.35-3.39.ppm) and FT-IR (disappearance of the charac- 
teristic azide peak at 2100 cm
-1
) that confirmed a complete re- 
duction of the azide groups (see ESI for further details). After 
solvent evaporation the crude was dissolved in H2O and  fil- 
tered through cotton, then it was washed with DCM and ly- 
ophilized to give Gn-NH2·HCl dendrimers in excellent yields   (96 
- 99%). 
G1-NH2HCl – 
1
H NMR (500 MHz, MeOD-d3) H: 7.3 (s, 6H), 6.16 
(s,  3H), 4.32  -  4.26  (m, 18H), 4.10  -  4.09  (m, 6H), 3.95  –  3.72 
(m, 96H), 3.64  –  3.62  (m, 6H), 3.21  –  3.17  (m, 18H). IR    (KBr) 
max:  2929, 1584, 1119 cm
-1
.  MALDI-TOF MS of  G1-N3    (HABA, 
reflected mode): m/z calcd for C99H156N30O39Na: 2412.1.  Found 
M+Na
+
: 2412.3. 
G2-NH2HCl – 
1
H NMR (500 MHz, MeOD-d3) H: 7.31 – 7.26 (m, 
24H), 6.17  (s,  3H), 4.29  -  4.20  (m, 72H), 4.11  -  4.09  (m,   6H), 
3.93  –  3.72  (m, 312H), 3.62  –  3.60  (m, 24H), 3.19  –  3.16  (m, 
54H). IR  (KBr) max:  2929, 1638, 1118 cm
-1
.  MALDI-TOF MS   of 
G2-N3 (HABA,       reflected       mode):       m/z     calcd       for 
C324H507N93O129Na: 7792.0. Found M+Na
+
: 7791.9. 
G3-NH2 HCl – 
1
H NMR (500 MHz, MeOD-d3) H: 7.32 – 7.27   (m, 
78H), 6.18  (s,  3H), 4.29  -  4.19  (m, 234H), 4.11  (bs,  6H), 3.92 – 
3.60  (m, 1038H), 3.20  –  3.16  (m, 162H). IR  (KBr) max:     2878, 
1638, 1117 cm
-1
. 
Fluorescent labelling of G3-NH2 
Stock solutions of  7-methoxycoumarin-3-carboxylic  acid 
(MCCA) (7.9 mg/mL in dry DCM), 1-ethyl-3-(3- 
dimethylaminopropyl)carbodiimide hydrochloride  (EDC·HCl) 
(6.9 mg/mL in dry DCM) and N-hydroxysuccinimide (NHS) (8.3 
mg/mL in dry MeOH) were prepared. 20 μL of those stock so- 
lutions (2.5 equiv.) were placed in a round-bottomed flask. 100 
equiv. of Et3N (3.6 L) were added. 7.1 mg of G3-NH2 were dis- 
solved in 600 μL of dry MeOH. This  dendrimer  solution  was 
then added slowly to the previous mixture under stirring and 
stirred overnight. The solvent was removed under a nitrogen 
flow, the crude re-dissolved in H2O and  dialysed  against H2O  
for 48 h (14 kDa MWCO). The labelling was confirmed by fluo- 
rimetry (ex  330 nm, em  402 nm). 
Bacteria strains and growth conditions 
V. harveyi BB170 was a gifts from Bonnie Bassler (Department  
of Molecular Biology, Princeton University). V. harveyi BB170 
was grown from a frozen stock on Luria Bertani (LB) agar   plates 
containing 50 μg/mL kanamycin. Bacteria were incubated 
overnight at 30 C with 50  μg/mL kanamycin. LB  medium: 10 g/L 
of tryptone, 5 g/L of yeast extract and 10 g/L of NaCl. This 
medium was autoclaved at 120 C for 20 min before  use. 
 
Aggregation Assay 
A single colony of V. harveyi from LB agar plates was used to 
inoculate 2 mL of LB medium containing 50 g/mL kanamycin 
and incubated overnight at 30 C. Bacteria were centrifuged at 
9,000 rpm for 5 min at  4  C,  the  supernatant was discarded and 
bacteria re-suspended in PBS. This washing step was re- peated 
two times and bacteria were finally re-suspended at an OD600 = 
1.0. Aliquots of the bacteria culture were mixed with known 
volumes of stock solutions of Gn-NH2 in PBS. The values of the 
concentrations reported correspond to the final concen- tration 
(mg/mL) of dendrimer in the  bacteria-suspension. 
Size: Mean size and size distributions of bacterial clusters were 
determined under moderate stirring (default speed 5-6 setting, 
Beckman Coulter LS230) at the required concentration as indi- 
cated by the in-built display software. Aliquots of the den- 
drimer-bacteria suspension in PBS were taken  at  different times 
(5-60 min range) and added to a Coulter flow cell  filled with H2O 
(<14 mL) to reach the required optical obstruction indicated  by  
the  built-in  software  (8-12%, between 500-1,500 
L). Particle size ranges were defined using  PSS-Duke  stand- 
ards (Polymer Standard Service), Kromatek Ltd., Dunmow, UK). 
Particle size or cluster size distribution was determined as a 
function of the particle diffraction using the Coulter software 
(version 2.11) and plotted as a function of the percentage of 
distribution volume. Cluster size was measured in triplicate at 
each time point. Experiment was repeated three  times. 
Microscopy: 10 L of the Gn-NH2–bacteria suspension in PBS 
used for measuring cluster size were taken after 60 min and 
mounted on a glass slide with a cover slip for optical and con- 
focal microscopy imaging. For confocal microscopy, 10 L of a 
solution of the MCCA labelled G3-NH2 was added to 90 L bac- 
teria in PBS and incubated for 60 min. 1 L of  SYTO-9  stain 
(0.033 mM in DMSO) was added to this dendrimer-bacteria 
suspension and incubated in the dark for 10 min at room tem- 
perature prior to imaging. For SYTO-9; ex = 488 and em = 522, for 
MCCA; ex = 405 and em = 460. In all cases, confocal micro- 
graphs have the following colour representation: green (green 
channel) and magenta (blue channel). 
 
Membrane Permeability using Flow Cytometry 
A single colony of V. harveyi from LB agar plates was used to 
inoculate 2 mL of LB medium containing 50 g/mL kanamycin 
and incubated overnight at 30 C. Bacteria were then centri- 
fuged at 9,000 rpm for 5 min, supernatant was discarded and 
bacteria were re-suspended in  AB  medium  or PBS at an   OD600 
= 1.0. For membrane permeability during aggregation assays  in 
PBS; 90 L of the bacteria culture was added to 10 L of stock 
solutions of Gn-NH2 in H2O or H2O alone (control) and incubat- 
ed for 1 h at room temperature. 1 L of a mixture of SYTO-9 
stain (0.033 mM in DMSO) and propidium iodide (20 mM in 
DMSO) (PI) 1:1.5 was added to each sample and incubated at 
room  temperature in  the  dark  for 10 min  prior to experiment. 
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For membrane permeability during luminescence experiment; 
bacteria were diluted 5,000-fold in AB medium. 90 μL bacteria  
in AB medium was mixed with 10 L of stock solutions of Gn- 
NH2 in H2O or H2O alone (control). Bacteria-dendrimer suspen- 
sions were incubated at 30 C for 10 h, thereafter, centrifuged 
for 5 min at 9,000 rpm and re-suspended in 500 L of 0.85% 
NaCl. 1 L of a mixture of SYTO-9 stain (0.033 mM in DMSO)   
and PI (200 mM in DMSO) 1:1 was added to each sample and 
incubated at room temperature in the dark for 10 min prior to 
experiment. Negative controls were incubated with 70%  i-  
PrOH for 1 h followed by 2 washes with media (centrifugation 
10,000 rpm, 5 min, rt). Bacteria were counted in a Flow Cy- 
tometer. 100,000 events per sample were counted. The values 
of the concentrations reported correspond to the final concen- 
tration (mg/mL) of dendrimer in the bacteria-suspension. Each 
condition was done in triplicate and the experiment was re- 
peated three times. Data were analysed using Kaluza Flow 
Analysis Software (Beckman Coulter Inc.). 
 
Luminescence Assay 
A single colony of V. harveyi from LB agar plates was used to 
inoculate 2 mL LB medium containing  50  g/mL  kanamycin 
and  incubated overnight at 30  C. Bacteria were then  diluted  
to OD600 = 1.0 in boron-depleted Assay Broth (AB) medium and 
then inoculated in the same medium (5,000:1). Boric acid was 
added to a final concentration of 22 M. 180 L of the inocu- 
lated AB medium was added to each  well of  a  96-well plate  
and mixed with 20 L of the sample to be analysed. Light pro- 
duction and OD600 were recorded at 30 C every 30 min for at 
least 10 h in a 96-well plate. The normalized luminescence was 
calculated by dividing the light output by the optical density at 
each time point. Luminescence recovery time was defined as  
the time for normalised luminescence to reach the initial value 
for each individual sample. Each compound was tested over at 
least 3 different concentrations and each  concentration  was 
run in triplicate. Experiment was repeated three times. AB 
Medium: 0.3 M NaCl, 0.05 M MgSO4 x 7H2O, 0.2% vitamin-free 
casamino acids, 1 mM L-arginine, 1% glycerol, 0.01 M K2HPO4, 
pH 7.0. This medium was autoclaved at 120 C for 20 min be- 
fore use. 
 
Results and discussion 
Dendrimers are attractive materials to interface with biology.
41-
43
. They are monodisperse polymers, with controlled sizes and 
numbers of terminal groups that can present biologi- cal 
information (e.g. multiple copies of ligands or drugs) in a precise 
and unique spatial arrangement. Not surprisingly, den- drimers 
have been investigated as mimics of  natural  ligands (e.g. 
glycans) and exploited to interfere with host-pathogen in- 
teractions.
13-15 
In this work, we decided to investigate the po- 
tential of GATG dendrimers to develop novel antimicrobial 
agents. GATG dendrimers are composed of a repeating unit in- 
corporating a gallic acid core and hydrophilic triethylene glycol 
arms.
29 
They are biocompatible, and easy to manufacture and 
scale up. Generations in GATG dendrimers are grown following 
a  two-step  reaction  sequence  involving  an  initial  amide cou- 
pling between the terminal amines at a certain generation and 
the carboxylic acid at the GATG repeating unit, followed by re- 
duction of the azides to afford a new layer of primary amines 
(Scheme 1). This strategy can be easily scaled-up to multigram 
quantities of these materials.
39 
Here, we evaluate the antimi- 
crobial activity of a new family of GATG dendrimers prepared 
using a 1,3,5-tri(2-(2-(2-aminoethoxy)ethoxy)ethoxy)benzene 
core. As opposed to traditional GATG dendrimers that carry a 
gallic acid core, this new family is expected to display a more 
globular architecture. Dendrimers with 9, 27 and 81 primary 
amines, corresponding to generations G1-NH2 – G3-NH2, were 
obtained by quantitative reduction of the peripheral azides, 
easily monitored using FT-IR spectroscopy (Figure S1) (com- 
plete disappearance of the azide signal at 2100 cm
-1
) and de- 
termined by 
1
H-NMR (disappearance of the CH2N3 peak at 3.35-
3.39 ppm) (Figure S2).
40
 
Clustering of V. harveyi by Gn-NH2 
The first potential antimicrobial strategy that we  evaluated  
was adhesion and clustering of bacteria. Previous work in our 
group has shown that linear cationic polymers readily form 
polymer-bacteria clusters by electrostatic interactions with the 
negatively charged bacterial surface.
12, 17, 18 
Herein, by using 
aminodendrimers where the size and number of terminal  
groups can be accurately controlled by design, we aimed to 
modulate systematically the antimicrobial properties of these 
polycations. We anticipated that the globular and branched 
architecture of GATG dendrimers would have a beneficial gen- 
eration dependent effect on their interaction with bacterial 
membranes and thus in clustering. As in our previous reports, 
we used V. harveyi, an opportunistic marine pathogen, as a 
model organism. It is closely related to human pathogens Vib-  
rio cholerae and Vibrio parahaemolyticus and, like these mi- 
crobes, uses a complex signalling network to regulate its viru- 
lence.
44 
Importantly, V. harveyi is luminescent and this lumi- 
nescence provides an easy readout to evaluate V. harveyi via- 
bility and behaviour. 
When V. harveyi BB170 was incubated with  GATG dendrimers  
a clear generation dependent increase in cluster formation  
could be observed (Figure  2). The ability  of  these dendrimers  
to cluster bacteria was compared to linear p(DMAPMAm), pre- 
viously used in our laboratories for this purpose. The high clus- 
tering ability of GATG dendrimers allowed for these experi- 
ments to be performed in PBS which was significant because 
under these conditions none of the p(DMAPMAm) polymers 
tested  (DP46 and  DP99) were able  to  induce any  clustering of 
V. harveyi (Figure 2A). While no apparent increase in  cluster  
size was observed for G1-NH2, which only has  9  primary  
amines in its periphery (Figure 2A), a clear increase in cluster  
size was immediately apparent when V. harveyi BB170 was in- 
cubated with the dendrimers of higher generations, with clus- 
ters of over 4.5 μm forming for G3-NH2. Inspection of the size 
distributions (Figure 2B) suggested that as the  multivalency of 
the dendrimer increased, the number of free bacteria (popula- 
tion centred at 1 μm) was reduced. A similar effect could be 
observed  when  these  clusters  were  inspected  under  the mi- 
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croscope (Figure 2C), with aggregates of increasing size form-  
ing with increasing dendrimer generation. 
It is worth noting that the average size obtained for the bacte- 
ria in the presence of G1-NH2 was slightly smaller (orange tri- 
angles, Figure 1B, 0.6 μm) than that of V. harveyi in the ab- 
sence of the dendrimers (black triangles, Figure 1B, 0.9 μm). 
However, since reported bacteria  sizes  are  measured  relative 
to calibrants (i.e. polystyrene beads),  they  do  not  represent 
the actual size expected for V. harveyi (1.5 μm), but do in-  
form of relative changes in size. Taking into account the size of 
these dendrimers (less than 3 nm for G1-NH2, 3.6 nm for G2- 
NH2, and 5.7 nm for G3-NH2; Table S1), it is quite reasonable  
that G1-NH2 does not have the minimum required size and 
multivalency  to  efficiently  bridge  between  multiple   bacteria 
and none or few small clusters are formed. Size distributions in 
the presence of G1-NH2 were narrower (0.25-1.05 μm) than in 
its absence (0.30-3.00  μm), suggesting  that G1-NH2  still  binds 
to the surface of V. harveyi and modifies its surface properties, 
potentially preventing the natural tendency of microbes to ag- 
gregate. A  similar reduction in size could be observed as well   
for the population of smaller size when V. harveyi was incu- 
bated with G2-NH2 (0.75 μm) and G3-NH2 (0.65 μm), sug- 
gesting that these cationic dendrimers were able to bind to V. 
harveyi and, depending on their size and multivalency, also in- 
duce the formation of bacterial clusters. 
Further evidence of the interaction between Gn-NH2 den- 
drimers and V. harveyi was obtained from ζ-potential meas- 
urements. As expected, the bacteria presented an overall neg- 
ative potential (-64.4 ± 5.9 mV, Figure S6), representative of 
their negatively charged membranes. In the presence of the 
dendrimers however this negative potential was  reduced.  
Once again, this effect was generation dependent,  with  G3- 
NH2 showing the biggest effect. 
In order to verify that the dendrimers were co-located with   the 
bacteria in the clusters, G3-NH2 was labeled with MCCA, a fluo- 
rescent blue dye, and incubated with V. harveyi BB170 stained 
with SYTO-9, a fluorescent green dye permeable to microbial 
membranes (Figure 1 and Figure S5). Co-localization was ap- 
parent by comparing the green (SYTO-9, bacteria) and magen-  
ta (MCCA labelled G3-NH2) channels in confocal laser scanning 
microscopy (Figure 1). Z-stack analysis showed that the MCCA 
labelled G3-NH2 is present throughout the cluster. The high 
density of white fluorescent clusters and the absence of green 
fluorescence within the clusters  indicates  colocalization  of 
both dyes suggesting that this cationic GATG  dendrimer  was 
able to bind to the bacterial  membrane.
12
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: A) Mean cluster size of V. harveyi BB170 in the absence (black) and presence of G1-NH2 (orange), G2-NH2 (green), G3-NH2 (blue), and p(DMAPMAm) polymer DP46 
(light grey) and DP 99 (dark grey). B) Size distribution of V. harveyi‘s clusters in the absence (black) and presence of G1-NH2 (orange), G2-NH2 (green) and G3-NH2 (blue). C) Ag- 
gregation as observed by optical microscopy (100X magnification). The black bar represents 30 m. Initial OD600 = 1, [NH2] = 1.64 mM in PBS at pH 7.4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Confocal Laser Scanning Micrographs of V. harveyi BB170 (green) in the 
presence of MCCA labelled G3-NH2 (magenta). Ortho projections from the over- 
laid magenta and green channels (white) including Z-stacks without (A) and  with 
(B) transmission micrograph. Ortho projections for the blue (C) and green chan- 
nel with (D) and without (E) transmission micrograph. In all cases, blue channel 
has been depicted magenta for clarity. 
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Luminescence of V. harveyi in the presence of Gn-NH2 
Based on our previous work with linear cationic polymers,
17, 18 
we decided to investigate the ability of these dendrimers to 
modulate the expression of quorum sense controlled lumines- 
cence in V. harveyi. We anticipated that a generation depend- 
ent effect on the production of light should be observed, in 
agreement to that identified during the aggregation experi- 
ments (Figure 2-Figure 1). When V. harveyi BB170 was incu- 
bated with these dendrimers, a significant increase in the pro- 
duction of light was observed that was proportional to the 
amount of dendrimer added (Figure S9-Figure S11). When the 
same concentration of amines (e.g. 0.5 mM) was evaluated 
across the different dendrimers used, a clear generation effect 
could be observed (Figure 3). Light production  in  V.  harveyi 
was increased more than ten times when  it  was  incubated  
with G1-NH2 at this concentration, and over two orders of 
magnitude when treated with the highest generations of den- 
drimers. 
This increase was also apparent when we evaluated the time 
taken by  bacteria to  recover the  initial levels  of  luminescence 
(3  x  10
3
,   Figure  3B).  Under  normal  conditions,  V.   harveyi 
switches off light production following dilution into the assay 
broth and it takes almost 8 h for V. harveyi to reach a popula- 
tion density that can produce similar levels of  luminescence 
than the levels observed at the beginning of the experiment. In 
the presence of these GATG dendrimers however, this level of 
luminescence could be reached in as little as 6 h for the den- 
drimers of higher generation (Figure 3C). This generation ef-  
fect in recovery time was also observed at the other concen- 
trations of amino groups tested (0.25 and 1 mM, Figure S12). 
Such a significant increase in luminescence was noticeable, in 
particular considering the poor ability of G1-NH2 to cluster 
bacteria (Figure 2). This enhancement of light production was 
even more remarkable when we evaluated the effect these 
GATG dendrimers had on the growth of V. harveyi. Monitoring 
of optical density at 600 nm (OD600) during the luminescence 
experiments showed that all three Gn-NH2 were able to delay 
growth in V. harveyi (Figure S13-Figure S14), suggesting that V. 
harveyi were achieving similar levels of light  production  at  
even lower densities of bacteria. This effect was dose- 
dependent, but not generation dependent, with higher con- 
centrations of dendrimers showing the highest effect in micro- 
bial  growth. Remarkably, even  at  the  lowest concentration of 
amino groups evaluated (0.25 mM, Figure S9-Figure S14),  
where a negligible effect on growth could be observed for all 3 
generations of GATG dendrimers (Figure S13A), enhancement  
of light production could be  observed. 
Membrane permeability of V. harveyi in the presence of Gn-NH2 
Cationic polymers have been extensively investigated as po- 
tential mimics of antimicrobial peptides.
26-28 
Due to the cation-  
ic nature of our GATG dendrimers, we decided to investigate if 
they were able to induce membrane permeability and as such 
have an alternative mode of antimicrobial activity. In this re- 
gard, delayed growth of V. harveyi in the presence of  these 
GATG dendrimers was observed at the highest concentrations 
tested during luminescence (Figure S14), suggesting a poten-  
tial bacteriostatic effect. 
Incubation of V. harveyi (under the aggregation assay condi- 
tions) with a mixture of SYTO-9 and propidium iodide  (green  
and red stains for cells with intact and damaged membranes) 
revealed that as the generation of dendrimers increased, a 
growing number of bacteria were stained red (Figure 4 and 
Figure S7). This increase in red staining is indicative of higher 
permeability of the membrane with larger generations of den- 
drimer. While membrane permeability for G1-NH2 was not 
higher than control, over 50% of the bacteria were stained red  
in  the presence of G2-NH2  and up to 85%  in the case of G3-  
NH2, suggesting that these dendrimers could have a comple- 
mentary bactericidal effect. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Luminescence of V. harveyi BB170 in the absence (black) and presence of G1-NH2 (orange), G2-NH2 (green) and G3-NH2 (blue). [NH2] = 0.5 mM. A) Fold increase of 
luminescence, B) normalised luminescence, C) OD600 and D) recovery time. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Normalized population of V. harveyi BB170 presented as the percentage 
of green (non-permeable/viable) and red (high permeability/dead) cells as meas- 
ured by flow cytometry. V. harveyi was incubated in the absence (control) and 
presence of Gn-NH2 for 1h at room temperature. Bacteria were treated  with i-
PrOH as a negative control. Initial OD600  = 1, [NH2] = 1.64 mM in PBS at pH 7.4. 
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From the luminescence assays, all GATG dendrimers showed a 
remarkable effect on the production of light. However, at early 
time points Gn-NH2 showed a concentration-dependent bacte- 
riostatic effect (Figure S14), which was consistent across the 3 
generations of dendrimers tested (Figure  S13).  Accordingly,  
any reduction of the amount of light produced as a  result of   
the slower growth of V. harveyi should affect equally all gener- 
ations. At the same time, these dendrimers were inducing a 
generation dependent clustering and thereby were likely acti- 
vating quorum sense controlled light production in the order 
G1<G2<G3 (Figure 2-Figure 3).
18 
Moreover, membrane perme- 
ability assays showed that G2 and G3 dendrimers led to in- 
creasing membrane permeability under the conditions em- 
ployed to monitor aggregation (Figure 4), an effect that was al- 
so observed when this permeability assay was performed un- 
der the luminescence assay conditions (Figure S8). This is not 
unexpected, as membrane disruption has been observed for 
primary amines in multivalent scaffolds, but  can  be  alleviated  
if wanted with alternative cationic GATG dendrimers carrying 
secondary/tertiary amines or quaternary ammonium salts.
26-28 
This increased permeability caused by the higher generation 
dendrimers could facilitate the diffusion of quorum sensing au- 
toinducers inside the periplasm and thus enhance light pro- 
duction from the bacteria. Experiments to elucidate the rela-  
tive contributions of aggregation and permeability on light 
production have commenced in our laboratories using super- 
resolution microscopy. 
 
 
Conclusions 
In summary, in this manuscript we have evaluated how cation-  
ic GATG dendrimers interact with bacteria, interactions that 
could result in antimicrobial applications for this family of den- 
drimers. We have focused our evaluation in 3 areas – adhe- 
sion/clustering, signalling and membrane disruption  –  where 
we anticipate these dendrimers will have a higher  impact.  
Thus, we have shown that cationic GATG dendrimers induce 
clustering in V. harveyi in a generation dependent manner and 
that this clustering ability is greater than that of a cationic lin-   
ear polymer, p(DMAPMAm), previously shown to be a potent 
sequestrant of bacteria. Also, cationic GATG dendrimers in- 
duced the expression of quorum sense controlled lumines- 
cence in a generation dependent fashion, while inhibiting the 
growth of V. harveyi at the highest concentrations of amines 
tested. Moreover, these cationic dendrimers were able to in- 
crease the membrane permeability of the bacteria, again in a 
generation dependent manner. These results together high- 
light the potential of GATG dendritic materials as a platform to 
develop new antimicrobials that can target microbial viability 
and/or virulence (e.g. adhesion): Inhibition of growth and in- 
creased membrane permeability in combination with cell clus- 
tering may be promising antibacterial features of these cation-  
ic dendrimers. 
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